Literature DB >> 9632453

Venous thrombosis--the interaction of genes and environment.

R M Bertina, F R Rosendaal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9632453     DOI： 10.1056/NEJM199806183382510

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  The impact of molecular medicine upon early cardiovascular drug development.

Authors:  M W Lunnon; M Braddock
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

Review 2.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

3.  Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.

Authors:  J P Vandenbroucke
Journal:  BMJ       Date:  1998-08-22

4.  Genetic thrombophilia in patients with retinal vascular occlusion.

Authors:  K Greiner; D Peetz; A Winkgen; W Prellwitz; N Pfeiffer; G Hafner
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

5.  Cerebral Venous Thrombosis.

Authors:  Valérie Biousse; Frank Tong; Nancy J. Newman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

6.  Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy.

Authors:  Santiago L Bongiovanni; Maximiliano Ranalletta; Agustin Guala; Gaston D Maignon
Journal:  Clin Orthop Relat Res       Date:  2009-05-19       Impact factor: 4.176

7.  Cerebral Venous Thrombosis.

Authors:  Valérie Biousse; Frank Tong; Nancy J. Newman
Journal:  Curr Treat Options Neurol       Date:  2003-09       Impact factor: 3.598

8.  Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis.

Authors:  Ramazan Danis; Sehmus Ozmen; Davut Akin; Sabri Batun; Serdar Kahvecioglu; Abdullah Altintas; Mehmet E Yilmaz; Adil Polat
Journal:  J Thromb Thrombolysis       Date:  2008-03-25       Impact factor: 2.300

9.  Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

Authors:  F S Falvella; C Cremolini; R Miceli; F Nichetti; S Cheli; C Antoniotti; G Infante; A Martinetti; F Marmorino; E Sottotetti; R Berenato; M Caporale; A Colombo; F de Braud; M Di Bartolomeo; E Clementi; F Loupakis; F Pietrantonio
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550

Review 10.  Thrombophilia and pregnancy.

Authors:  Michael J Kupferminc
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.